Fundraising Fox
/Companies
Sign in

CHASE Pharmaceuticals

Washington, US · 3 known investors

Find your way into CHASE Pharmaceuticals

Sign up to see every warm intro you have to CHASE Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CHASE Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Irvine, CA based Alzheimer's drug company

Biotech

Founders & leadership

TN
Thomas N. ChaseFounder
DI
Douglas IngramExecutive
JM
John M. SiebertExecutive
KC
Kathleen Clarence-SmithNamed on SEC filing

Board

NG
Nayan Greg ParekhBoard director
JM
John M. ReherBoard directorManaging Director at Brain Trust Accelerator Fund
RWRaphael Wisniewski
Raphael WisniewskiBoard directorPartner at Andera Partners
SC
Stephen CunninghamBoard director
VS
Vikram SudarsanBoard director
GN
Greg N. ParekhBoard director
KN
Karoly NikolichBoard director

Investors · 3

New Rhein Healthcare Investors, LLClisted by New Rhein Healthcare Investors, LLCPhiladelphia

How we know: New Rhein Healthcare Investors, LLC's portfolio page · Not right? Tell us

Brain Trust Accelerator FundinferredBurlingamevia John M. Reher · board

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$21.6M disclosed across 3 of 5 rounds · 2014–2016

▶$12MraisedMar 2016 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathleen Clarence-SmithExecutive Officer
  • Vikram SudarsanDirector
  • Raphael WisniewskiDirector
  • Stephen CunninghamDirector
  • Nayan Greg ParekhDirector
  • Karoly NikolichDirector
  • John M. ReherDirector
  • Thomas N. ChaseExecutive Officer, Director
Offering amount
$12M
Amount sold
$12M
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$106.7KofferedFeb 2016 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen CunninghamDirector
  • Raphael WisniewskiDirector
  • Vikram SudarsanDirector
  • Nayan Greg ParekhDirector
  • John M. ReherDirector
  • Thomas N. ChaseExecutive Officer, Director
  • Karoly NikolichDirector
  • Kathleen Clarence-SmithExecutive Officer
  • Douglas IngramExecutive Officer, Director
Offering amount
$106.7K
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedFeb 2016 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Raphael WisniewskiDirector
  • Vikram SudarsanDirector
  • Stephen CunninghamDirector
  • Nayan Greg ParekhDirector
  • John M. ReherDirector, Executive Officer
  • Thomas N. ChaseExecutive Officer, Director
  • Karoly NikolichDirector
  • Douglas IngramDirector
  • Kathleen Clarence-SmithExecutive Officer
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$612.5KofferedFeb 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Nayan Greg ParekhDirector
  • Karoly NikolichDirector
  • Kathleen Clarence-SmithExecutive Officer
  • John M. ReherDirector
  • Raphael WisniewskiDirector
  • Douglas IngramExecutive Officer, Director
  • Thomas N. ChaseExecutive Officer, Director
  • Stephen CunninghamDirector
  • Vikram SudarsanDirector
Offering amount
$612.5K
First sale
Jan 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedMay 2014 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Raphael WisniewskiDirector
  • Greg N. ParekhDirector
  • Vikram SudarsanDirector
  • Thomas N. ChaseDirector
  • John M. ReherDirector
  • John M. SiebertExecutive Officer, Director
  • Karoly NikolichDirector
Offering amount
$8.6M
Amount sold
$6.1M
Minimum investment
$1
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does CHASE Pharmaceuticals do?
Irvine, CA based Alzheimer's drug company
Who founded CHASE Pharmaceuticals?
CHASE Pharmaceuticals was founded by Thomas N. Chase.
Who are CHASE Pharmaceuticals's investors?
CHASE Pharmaceuticals's investors include Andera Partners, New Rhein Healthcare Investors, LLC, Brain Trust Accelerator Fund.
How much funding has CHASE Pharmaceuticals raised?
CHASE Pharmaceuticals has disclosed $21.6M raised across 3 of its 5 known rounds.
Where is CHASE Pharmaceuticals headquartered?
CHASE Pharmaceuticals is headquartered in Washington, US.